Resting-state cortico-thalamic-striatal connectivity predicts response to dorsomedial prefrontal rTMS in major depressive disorder
- PMID: 24150516
- PMCID: PMC3870791
- DOI: 10.1038/npp.2013.222
Resting-state cortico-thalamic-striatal connectivity predicts response to dorsomedial prefrontal rTMS in major depressive disorder
Abstract
Despite its high toll on society, there has been little recent improvement in treatment efficacy for major depressive disorder (MDD). The identification of biological markers of successful treatment response may allow for more personalized and effective treatment. Here we investigate whether resting-state functional connectivity predicted response to treatment with repetitive transcranial magnetic stimulation (rTMS) to dorsomedial prefrontal cortex (dmPFC). Twenty-five individuals with treatment-refractory MDD underwent a 4-week course of dmPFC-rTMS. Before and after treatment, subjects received resting-state functional MRI scans and assessments of depressive symptoms using the Hamilton Depresssion Rating Scale (HAMD17). We found that higher baseline cortico-cortical connectivity (dmPFC-subgenual cingulate and subgenual cingulate to dorsolateral PFC) and lower cortico-thalamic, cortico-striatal, and cortico-limbic connectivity were associated with better treatment outcomes. We also investigated how changes in connectivity over the course of treatment related to improvements in HAMD17 scores. We found that successful treatment was associated with increased dmPFC-thalamic connectivity and decreased subgenual cingulate cortex-caudate connectivity, Our findings provide insight into which individuals might respond to rTMS treatment and the mechanisms through which these treatments work.
Figures




Similar articles
-
Changes in brain connectivity during a sham-controlled, transcranial magnetic stimulation trial for depression.J Affect Disord. 2018 May;232:143-151. doi: 10.1016/j.jad.2018.02.019. Epub 2018 Feb 21. J Affect Disord. 2018. PMID: 29494898 Free PMC article.
-
Prospective Validation That Subgenual Connectivity Predicts Antidepressant Efficacy of Transcranial Magnetic Stimulation Sites.Biol Psychiatry. 2018 Jul 1;84(1):28-37. doi: 10.1016/j.biopsych.2017.10.028. Epub 2017 Nov 10. Biol Psychiatry. 2018. PMID: 29274805 Free PMC article.
-
Association of Repetitive Transcranial Magnetic Stimulation Treatment With Subgenual Cingulate Hyperactivity in Patients With Major Depressive Disorder: A Secondary Analysis of a Randomized Clinical Trial.JAMA Netw Open. 2019 Jun 5;2(6):e195578. doi: 10.1001/jamanetworkopen.2019.5578. JAMA Netw Open. 2019. PMID: 31167023 Free PMC article.
-
Repetitive transcranial magnetic stimulation for treatment resistant depression: Re-establishing connections.Clin Neurophysiol. 2016 Nov;127(11):3394-3405. doi: 10.1016/j.clinph.2016.08.015. Epub 2016 Aug 31. Clin Neurophysiol. 2016. PMID: 27672727 Review.
-
[Repetitive transcranial magnetic stimulation in major depression: response factor].Encephale. 2012 Sep;38(4):360-8. doi: 10.1016/j.encep.2011.08.004. Epub 2011 Oct 11. Encephale. 2012. PMID: 22980479 Review. French.
Cited by
-
Converging Resting State Networks Unravels Potential Remote Effects of Transcranial Magnetic Stimulation for Major Depression.Front Psychiatry. 2020 Aug 20;11:836. doi: 10.3389/fpsyt.2020.00836. eCollection 2020. Front Psychiatry. 2020. PMID: 32973580 Free PMC article.
-
White matter integrity and functional predictors of response to repetitive transcranial magnetic stimulation for posttraumatic stress disorder and major depression.Depress Anxiety. 2019 Nov;36(11):1047-1057. doi: 10.1002/da.22952. Epub 2019 Sep 2. Depress Anxiety. 2019. PMID: 31475432 Free PMC article.
-
Neural and Behavioral Predictors of Treatment Efficacy on Mood Symptoms and Cognition in Mood Disorders: A Systematic Review.Front Psychiatry. 2018 Jul 26;9:337. doi: 10.3389/fpsyt.2018.00337. eCollection 2018. Front Psychiatry. 2018. PMID: 30093870 Free PMC article.
-
Effect of repetitive transcranial magnetic stimulation on patients with severe depression: a study protocol for systematic review and meta-analysis of randomised clinical trials.BMJ Open. 2021 Dec 14;11(12):e050098. doi: 10.1136/bmjopen-2021-050098. BMJ Open. 2021. PMID: 34907048 Free PMC article.
-
Theta-Burst Transcranial Magnetic Stimulation for Posttraumatic Stress Disorder.Am J Psychiatry. 2019 Nov 1;176(11):939-948. doi: 10.1176/appi.ajp.2019.18101160. Epub 2019 Jun 24. Am J Psychiatry. 2019. PMID: 31230462 Free PMC article. Clinical Trial.
References
-
- Alcaro A, Panksepp J, Witczak J, Hayes DJ, Northoff G. Is subcortical-cortical midline activity in depression mediated by glutamate and GABA? A cross-species translational approach. Neurosci Biobehav Rev. 2010;34:592–605. - PubMed
-
- Anand A, Li Y, Wang Y, Wu J, Gao S, Bukhari L, et al. Antidepressant effect on connectivity of the mood-regulating circuit: an FMRI study. Neuropsychopharmacology. 2005;30:1334–1344. - PubMed
-
- Beckmann CF, Jenkinson M, Smith SM. General multilevel linear modeling for group analysis in FMRI. Neuroimage. 2003;20:1052–1063. - PubMed
-
- Chen R, Gerloff C, Classen J, Wassermann EM, Hallett M, Cohen LG. Safety of different inter-train intervals for repetitive transcranial magnetic stimulation and recommendations for safe ranges of stimulation parameters. Electroencephalogr Clin Neurophysiol. 1997;105:415–421. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous